AIDS Alert Archives – September 1, 2008
September 1, 2008
View Issues
-
Shocking new HIV infection data spur call for major changes
HIV physicians and AIDS activists are calling for major changes in funding and prevention in light of the recent news that the estimated annual HIV infection rate in the U.S. has been off by 40% for about 15 years. -
Clinician front lines need more resources
Working as an HIV clinician in the United States today is largely about doing more with less. -
New OI prevention and treatment guidelines
HIV clinicians likely will find the latest version of the government's opportunistic infections (OIs) guidelines to be pertinent to their daily practice. This is especially true as the trend continues of patients being diagnosed with very low CD4 cell counts. -
Adherence Strategies: Study: Questionnaire accurately measures ART
One thing clinicians need as they work to keep their HIV patients adherent to their medication regimens is an accurate, simple tool for measuring drug adherence. -
FDA Notifications: Abacavir package insert changes approved
On July 18, 2008, the Food and Drug Administration (FDA) approved changes to the package insert for abacavir sulfate (Ziagen) highlighting information about the association of the HLA-B*5701 allele (a part of a gene) and hypersensitivity reactions (HSR) caused by abacavir-containing therapy. -
Stigmatized: Global survey shows HIV pts still fear it
Results from the AIDS Treatment for Life International Survey (ATLIS)which polled nearly 3,000 HIV-positive patients from 18 countriesshow people living with HIV and AIDS around the globe still live in fear of the societal stigma that surrounds the disease. -
Survey also shows fear of side effects undercuts care
Study results show that concerns about side effects may prevent patients from seeking treatment. -
WHO HIV/AIDS guide to help universal access
The World Health Organization (WHO) has created a package of priority interventions designed to help low- and middle-income countries move towards universal access to HIV/AIDS prevention, treatment, care and support. -
HIV PEP rarely warranted after mass casualties
The Centers for Disease Control and Prevention has issued recommendations for postexposure interventions to prevent infection with HIV and other bloodborne pathogens among the wounded during mass casualty events.